Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

CD2 might be a new treatment target for patchy alopecia areata.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

ILC1 cells contribute to hair loss in alopecia areata.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

People with alopecia areata often have lower vitamin D levels than healthy people.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Certain gene variations may increase the risk and severity of alopecia areata.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Certain genes are linked to the risk of developing Alopecia Areata.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

Upadacitinib may effectively treat alopecia areata without side effects.